Long-term Follow-up of Subfoveal Neovascular AMD

• Conditions: Exudative Age-related Macular Degeneration

• Registration Number: NCT01608113
• Lead Sponsor: Medical University of Vienna

Brief Summary

Treatment naive patients with subfoveal nAMD initially treated monthly with intravitreal anti-VEGF and subsequently PRN, will be included in this study. Patients will be investigated for the first 2 years monthly and subsequently according to disease activity but at least every two months. Patients will be examined with 4m BCVA ETDRS distance visual acuity, reading acuity measured by Radner-Reading-Charts, contrast sensitivity by Pelli-Robson score, microperimetry and HD-OCT.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2012-04-10
• Status Verified: 2012-05
• Study First Submitted QC: 2012-05-25
• Last Update Submitted: 2012-05-25
• Study First Posted: 2012-05-30
• Last Update Posted: 2012-05-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• treatment naive subfoveal AMD, written informed consent, able to read

Read More

Exclusion Criteria

• choroidal neovascularisation due to other ocular diseases, mature cataract

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Long-term visual function performance	four years

Secondary Outcome Measures

Name	Time	Method
change of morphological alterations assessed by SD-OCT	four years

Trial Locations

Locations (1)

Department of Ophthalmology Medical University of Vienna; 🇦🇹 Vienna, Austria